Revolution Medicines, Inc. financial data

Symbol
RVMD, RVMDW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
700 Saginaw Dr, Redwood City, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.41K % +19.1%
Debt-to-equity 12.6 % -23.7%
Return On Equity -34.6 % +5.21%
Return On Assets -30.7 % +1.92%
Operating Margin -81K % -7319%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 167M shares +53%
Common Stock, Shares, Outstanding 166M shares +51.8%
Entity Public Float 2.76B USD +124%
Common Stock, Value, Issued 16K USD +45.5%
Weighted Average Number of Shares Outstanding, Basic 165M shares +54.5%
Weighted Average Number of Shares Outstanding, Diluted 165M shares +54.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 742K USD -97.5%
Research and Development Expense 509M USD +68.3%
General and Administrative Expense 92.3M USD +87.6%
Operating Income (Loss) -601M USD -86.5%
Nonoperating Income (Expense) 78M USD +205%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -523M USD -76.2%
Income Tax Expense (Benefit) -3.52M USD -739%
Net Income (Loss) Attributable to Parent -519M USD -75.3%
Earnings Per Share, Basic -3.84 USD/shares -23.1%
Earnings Per Share, Diluted -3.84 USD/shares -23.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 276M USD -27.5%
Marketable Securities, Current 1.32B USD +149%
Assets, Current 1.62B USD +76.2%
Property, Plant and Equipment, Net 25.3M USD +28.2%
Operating Lease, Right-of-Use Asset 75.3M USD +40.1%
Intangible Assets, Net (Excluding Goodwill) 57.2M USD -1.83%
Goodwill 14.6M USD 0%
Other Assets, Noncurrent 8.27M USD +207%
Assets 1.81B USD +68.4%
Accounts Payable, Current 29.3M USD -1.56%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 105M USD +34.9%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Deferred Income Tax Liabilities, Net 3.12M USD -55.7%
Operating Lease, Liability, Noncurrent 79.1M USD +37.4%
Other Liabilities, Noncurrent 656K USD +160%
Liabilities 190M USD +32.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.86M USD -48.9%
Retained Earnings (Accumulated Deficit) -1.39B USD -59.8%
Stockholders' Equity Attributable to Parent 1.62B USD +73.9%
Liabilities and Equity 1.81B USD +68.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -161M USD -157%
Net Cash Provided by (Used in) Financing Activities 810K USD -99.8%
Net Cash Provided by (Used in) Investing Activities -248M USD -6305%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 171M shares +56.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -408M USD -253%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 279M USD -27.2%
Deferred Tax Assets, Valuation Allowance 377M USD +68.1%
Deferred Tax Assets, Gross 404M USD +61.2%
Operating Lease, Liability 87.4M USD +38.2%
Depreciation 5.78M USD +26.2%
Payments to Acquire Property, Plant, and Equipment 3.17M USD +80.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -520M USD -75.8%
Lessee, Operating Lease, Liability, to be Paid 141M USD +32.1%
Property, Plant and Equipment, Gross 45.7M USD +25.1%
Operating Lease, Liability, Current 8.33M USD +45.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 10.8M USD +47.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 10.5M USD +47.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 54.1M USD +26.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 11.2M USD +47.5%
Deferred Tax Assets, Operating Loss Carryforwards 148M USD +11.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 191M USD +2418%
Lessee, Operating Lease, Liability, to be Paid, Year Four 11.6M USD +47.5%
Operating Lease, Payments 2.3M USD -14.3%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.07M USD -0.09%
Depreciation, Depletion and Amortization 1.21M USD +33.7%
Deferred Tax Assets, Net of Valuation Allowance 26.9M USD +2.39%
Share-based Payment Arrangement, Expense 75.1M USD +91.8%
Interest Expense 0 USD -100%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%